← Back to Search

Other

Treatment for Retinitis Pigmentosa (IHR Trial)

N/A
Waitlist Available
Led By Michel PAQUES
Research Sponsored by Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from date of inclusion until the date of last documented progression , assessed up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

To increase the clinical experience of using the rtx1 camera in various retinal disorders and to follow the evolution of structural alterations during retinal diseases using adaptive optics imaging with the rtx1 camera

Eligible Conditions
  • Retinitis Pigmentosa
  • Diabetic Retinopathy
  • Macular Degeneration
  • Macular Edema
  • High Blood Pressure
  • Retinal Vein Occlusion
  • Retinal Degeneration
  • Cystoid Macular Edema
  • Age-Related Macular Degeneration

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from date of inclusion until the date of last documented progression , assessed up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and from date of inclusion until the date of last documented progression , assessed up to 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evolution of retina diseases

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsLead Sponsor
21 Previous Clinical Trials
7,046 Total Patients Enrolled
7 Trials studying Retinitis Pigmentosa
2,694 Patients Enrolled for Retinitis Pigmentosa
Michel PAQUESPrincipal InvestigatorCentre Hospitalier National d'Ophtalmologie des Quinze-Vints
2 Previous Clinical Trials
2,400 Total Patients Enrolled
2 Trials studying Retinitis Pigmentosa
2,400 Patients Enrolled for Retinitis Pigmentosa
~128 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top